Antimalarial target vulnerability of the putative Plasmodium falciparum methionine synthase

被引:1
作者
Leela, Nirut [1 ]
Prommana, Parichat [2 ]
Kamchonwongpaisan, Sumalee [2 ]
Taechalertpaisarn, Tana [1 ]
Shaw, Philip J. [2 ]
机构
[1] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Bangkok, Thailand
[2] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand
关键词
Plasmodium falciparum; Methionine synthase; Malaria; GlmS riboswitch; GlmS ribozyme; Target vulnerability; DIHYDROFOLATE-REDUCTASE; PARASITE; METABOLISM; HYDROLASE;
D O I
10.7717/peerj.16595
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Plasmodium falciparum possesses a cobalamin-dependent methionine synthase (MS). MS is putatively encoded by the PF3D7_1233700 gene, which is orthologous and syntenic in Plasmodium. However, its vulnerability as an antimalarial target has not been assessed. Methods. We edited the PF3D7_1233700 and PF3D7_0417200 (dihydrofolate reductase-thymidylate synthase, DHFR-TS) genes and obtained transgenic P. falci-parum parasites expressing epitope-tagged target proteins under the control of the glmS ribozyme. Conditional loss-of-function mutants were obtained by treating transgenic parasites with glucosamine. Results. DHFR-TS, but not MS mutants showed a significant proliferation defect over 96 h, suggesting that P. falciparum MS is not a vulnerable antimalarial target.
引用
收藏
页数:17
相关论文
共 50 条
[11]   Molecular and Biological Aspects of Antimalarial Resistance in Plasmodium falciparum and Plasmodium vivax [J].
Bustamante, Carolina ;
Batista, Camila Nunes ;
Zalis, Mariano .
CURRENT DRUG TARGETS, 2009, 10 (03) :279-290
[12]   Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs [J].
Kagami, Luciano Porto ;
das Neves, Gustavo Machado ;
Rodrigues, Ricardo Pereira ;
da Silva, Vinicius Barreto ;
Eifler-Lima, Vera Lucia ;
Kawano, Daniel Fabio .
MOLECULAR DIVERSITY, 2017, 21 (03) :677-695
[13]   Structural model of the Plasmodium falciparum Thioredoxin reductase: a novel target for antimalarial drugs [J].
Banerjee, Amit Kumar ;
Arora, Neelima ;
Murty, U. S. N. .
JOURNAL OF VECTOR BORNE DISEASES, 2009, 46 (03) :171-183
[14]   Plasmodium falciparum:: Interaction of shikimate analogues with antimalarial drugs [J].
McRobert, L ;
Jiang, SD ;
Stead, A ;
McConkey, GA .
EXPERIMENTAL PARASITOLOGY, 2005, 111 (03) :178-181
[15]   Novel putative protective antigens of Plasmodium falciparum [J].
Sharma, S ;
Bhattacharyya, MK .
INDIAN JOURNAL OF MEDICAL RESEARCH, 1997, 106 :63-69
[16]   Population biology and antimalarial resistance:: The transmission of antimalarial drug resistance in Plasmodium falciparum [J].
Barnes, KI ;
White, NJ .
ACTA TROPICA, 2005, 94 (03) :230-240
[17]   Selective inhibitors of Plasmodium falciparum glycogen synthase-3 (PfGSK-3): New antimalarial agents? [J].
Masch, Andreas ;
Kunick, Conrad .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (10) :1644-1649
[18]   DISTINCT DIMER INTERFACE OF PLASMODIUM FALCIPARUM THYMIDYLATE SYNTHASE: IMPLICATION FOR SPECIES-SPECIFIC ANTIMALARIAL DRUG DESIGN [J].
Chanama, Suchart ;
Chitnumsub, Penchit ;
Leartsakulpanich, Ubolsree ;
Chanama, Manee .
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2017, 48 (04) :722-736
[19]   CARBONIC ANHYDRASE IN Plasmodium falciparum: A USEFUL TARGET FOR ANTIMALARIAL DRUG DESIGNING AND MALARIA BLOCKING TRANSMISSION COMPOUNDS [J].
Agudelo R, Carlos D. ;
Corena-McLeod, Maria ;
Robledo R, Sara M. .
VITAE-REVISTA DE LA FACULTAD DE QUIMICA FARMACEUTICA, 2010, 17 (01) :91-100
[20]   Plasmodium RNA triphosphatase validation as antimalarial target [J].
Moliner-Cubel, Sonia ;
Bahamontes-Rosa, Noemi ;
Rodriguez-Alejandre, Ane ;
Nassau, Pamela M. ;
Argyrou, Argyrides ;
Bhardwaja, Anshu ;
Buxton, Rachel C. ;
Calvo-Vicente, David ;
Mouzon, Bernadette ;
McDowell, William ;
Mendoza-Losana, Alfonso ;
Gomez-Lorenzo, Maria G. .
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2024, 25